Financial Performance - For the six months ended June 30, 2022, the company reported revenue of RMB 114,922,000, a decrease of 10.5% compared to RMB 128,443,000 for the same period in 2021[21] - Gross profit for the same period was RMB 41,434,000, down 18% from RMB 50,687,000 in the previous year[21] - The company recorded a net loss of RMB 1,507,000 for the six months ended June 30, 2022, compared to a net loss of RMB 782,000 for the same period in 2021[21] - Total revenue from the oral care products segment for the six months ended June 30, 2022, was RMB 52,744,000, down from RMB 56,812,000 in the same period of 2021, reflecting a decrease of approximately 7.5%[41] - Total revenue from the leather care products segment for the six months ended June 30, 2022, was RMB 6,081,000, down from RMB 8,961,000 in the same period of 2021, indicating a decline of approximately 32.5%[41] - Total revenue from the household hygiene products segment for the six months ended June 30, 2022, was RMB 56,097,000, down from RMB 62,670,000 in the same period of 2021, representing a decrease of approximately 10.4%[41] - The total loss before tax for the six months ended June 30, 2022, was RMB (1,574,000), compared to a loss of RMB (847,000) for the same period in 2021, indicating a worsening financial performance[41] - The company reported a net loss attributable to owners of RMB 1,507,000 for the six months ended June 30, 2022, compared to a loss of RMB 782,000 in the same period of 2021[60] - The overall gross margin for the period was approximately 36.1%, down from 39.5% in the same period last year, a decrease of about 3.4%[103] Cash Flow and Assets - The company's cash and cash equivalents decreased to RMB 31,291,000 from RMB 68,596,000 at the end of 2021[23] - Net cash used in operating activities for the six months ended June 30, 2022, was RMB (26,358,000), compared to RMB (22,619,000) for the same period in 2021, indicating a decline in cash flow from operations[27] - Cash and cash equivalents decreased by RMB 38,146,000 during the six months ended June 30, 2022, compared to a decrease of RMB 25,640,000 in the same period of 2021[27] - The cash balance at the end of the period was RMB 31,291,000, down from RMB 49,455,000 at the end of the same period in 2021, reflecting a decline of approximately 36.7%[27] - Total assets as of June 30, 2022, were RMB 248,666,000, slightly down from RMB 249,268,000 as of December 31, 2021[23] - Total assets as of June 30, 2022, were RMB 308,573,000, a decrease of 12.6% from RMB 353,015,000 as of December 31, 2021[52] Inventory and Receivables - Inventory increased to RMB 38,926,000 as of June 30, 2022, from RMB 32,560,000 at the end of 2021[23] - As of June 30, 2022, trade receivables amounted to RMB 34,641,000, a decrease of 28.5% from RMB 48,448,000 as of December 31, 2021[10] - The aging analysis of trade receivables shows that amounts overdue by 0 to 30 days decreased to RMB 30,748,000 from RMB 40,735,000, representing a decline of 24.5%[74] - The total trade and other payables as of June 30, 2022, were RMB 41,095,000, down 27.8% from RMB 56,865,000 as of December 31, 2021[82] Management and Strategy - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[19] - The management highlighted ongoing efforts in research and development for new products and technologies to drive future growth[19] - The company plans to enhance the development of enzyme-based biocidal products to increase market share in household hygiene products[98] Employee and Compensation - The group employed 264 full-time employees, with employee costs amounting to approximately RMB 7.9 million during the period[118] - The total compensation for directors and key management personnel was RMB 764,000 for the six months ended June 30, 2022, down from RMB 823,000 in the same period of the previous year[91] Dividends and Shareholder Information - The company did not declare any dividends for the six months ended June 30, 2022, consistent with the previous year[64] - The company does not recommend the payment of an interim dividend for the period[110] - Major shareholders include Zhongbao Mali with a 57.56% stake and Tongxing Holdings with a 10.69% stake as of June 30, 2022[126] Compliance and Governance - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited consolidated results for the six months ending June 30, 2022, and confirmed compliance with applicable accounting standards and GEM Listing Rules[137] - The company has maintained sufficient public float as required by GEM Listing Rules since the listing date[140] - The interim results announcement and report for the six months ending June 30, 2022, are available on the Hong Kong Stock Exchange website and the company's website[140]
中国金典集团(08281) - 2022 - 中期财报